215 related articles for article (PubMed ID: 24291866)
1. [ALS disease modeling and drug screening using patient-specific iPS cells].
Egawa N; Inoue H
Rinsho Shinkeigaku; 2013; 53(11):1020-2. PubMed ID: 24291866
[TBL] [Abstract][Full Text] [Related]
2. Drug screening for ALS using patient-specific induced pluripotent stem cells.
Egawa N; Kitaoka S; Tsukita K; Naitoh M; Takahashi K; Yamamoto T; Adachi F; Kondo T; Okita K; Asaka I; Aoi T; Watanabe A; Yamada Y; Morizane A; Takahashi J; Ayaki T; Ito H; Yoshikawa K; Yamawaki S; Suzuki S; Watanabe D; Hioki H; Kaneko T; Makioka K; Okamoto K; Takuma H; Tamaoka A; Hasegawa K; Nonaka T; Hasegawa M; Kawata A; Yoshida M; Nakahata T; Takahashi R; Marchetto MC; Gage FH; Yamanaka S; Inoue H
Sci Transl Med; 2012 Aug; 4(145):145ra104. PubMed ID: 22855461
[TBL] [Abstract][Full Text] [Related]
3. Modeling hallmark pathology using motor neurons derived from the family and sporadic amyotrophic lateral sclerosis patient-specific iPS cells.
Sun X; Song J; Huang H; Chen H; Qian K
Stem Cell Res Ther; 2018 Nov; 9(1):315. PubMed ID: 30442180
[TBL] [Abstract][Full Text] [Related]
4. Motor neuron differentiation of iPSCs obtained from peripheral blood of a mutant TARDBP ALS patient.
Bossolasco P; Sassone F; Gumina V; Peverelli S; Garzo M; Silani V
Stem Cell Res; 2018 Jul; 30():61-68. PubMed ID: 29800782
[TBL] [Abstract][Full Text] [Related]
5. Advances in Patient-Specific Induced Pluripotent Stem Cells Shed Light on Drug Discovery for Amyotrophic Lateral Sclerosis.
Lee JH; Liu JW; Lin SZ; Harn HJ; Chiou TW
Cell Transplant; 2018 Sep; 27(9):1301-1312. PubMed ID: 30033758
[TBL] [Abstract][Full Text] [Related]
6. The fused in sarcoma protein forms cytoplasmic aggregates in motor neurons derived from integration-free induced pluripotent stem cells generated from a patient with familial amyotrophic lateral sclerosis carrying the FUS-P525L mutation.
Liu X; Chen J; Liu W; Li X; Chen Q; Liu T; Gao S; Deng M
Neurogenetics; 2015 Jul; 16(3):223-31. PubMed ID: 25912081
[TBL] [Abstract][Full Text] [Related]
7. Reverse engineering human neurodegenerative disease using pluripotent stem cell technology.
Liu Y; Deng W
Brain Res; 2016 May; 1638(Pt A):30-41. PubMed ID: 26423934
[TBL] [Abstract][Full Text] [Related]
8. A cellular model for sporadic ALS using patient-derived induced pluripotent stem cells.
Burkhardt MF; Martinez FJ; Wright S; Ramos C; Volfson D; Mason M; Garnes J; Dang V; Lievers J; Shoukat-Mumtaz U; Martinez R; Gai H; Blake R; Vaisberg E; Grskovic M; Johnson C; Irion S; Bright J; Cooper B; Nguyen L; Griswold-Prenner I; Javaherian A
Mol Cell Neurosci; 2013 Sep; 56():355-64. PubMed ID: 23891805
[TBL] [Abstract][Full Text] [Related]
9. Pathological Modification of TDP-43 in Amyotrophic Lateral Sclerosis with SOD1 Mutations.
Jeon GS; Shim YM; Lee DY; Kim JS; Kang M; Ahn SH; Shin JY; Geum D; Hong YH; Sung JJ
Mol Neurobiol; 2019 Mar; 56(3):2007-2021. PubMed ID: 29982983
[TBL] [Abstract][Full Text] [Related]
10. Motor neuron translatome reveals deregulation of SYNGR4 and PLEKHB1 in mutant TDP-43 amyotrophic lateral sclerosis models.
Marques RF; Engler JB; Küchler K; Jones RA; Lingner T; Salinas G; Gillingwater TH; Friese MA; Duncan KE
Hum Mol Genet; 2020 Sep; 29(16):2647-2661. PubMed ID: 32686835
[TBL] [Abstract][Full Text] [Related]
11. Progressive Motor Neuron Pathology and the Role of Astrocytes in a Human Stem Cell Model of VCP-Related ALS.
Hall CE; Yao Z; Choi M; Tyzack GE; Serio A; Luisier R; Harley J; Preza E; Arber C; Crisp SJ; Watson PMD; Kullmann DM; Abramov AY; Wray S; Burley R; Loh SHY; Martins LM; Stevens MM; Luscombe NM; Sibley CR; Lakatos A; Ule J; Gandhi S; Patani R
Cell Rep; 2017 May; 19(9):1739-1749. PubMed ID: 28564594
[TBL] [Abstract][Full Text] [Related]
12. Altered astrocytic expression of TDP-43 does not influence motor neuron survival.
Haidet-Phillips AM; Gross SK; Williams T; Tuteja A; Sherman A; Ko M; Jeong YH; Wong PC; Maragakis NJ
Exp Neurol; 2013 Dec; 250():250-9. PubMed ID: 24120466
[TBL] [Abstract][Full Text] [Related]
13. Specific vulnerability of iPSC-derived motor neurons with TDP-43 gene mutation to oxidative stress.
Onda-Ohto A; Hasegawa-Ogawa M; Matsuno H; Shiraishi T; Bono K; Hiraki H; Kanegae Y; Iguchi Y; Okano HJ
Mol Brain; 2023 Jul; 16(1):62. PubMed ID: 37496071
[TBL] [Abstract][Full Text] [Related]
14. 4-Aminopyridine Induced Activity Rescues Hypoexcitable Motor Neurons from Amyotrophic Lateral Sclerosis Patient-Derived Induced Pluripotent Stem Cells.
Naujock M; Stanslowsky N; Bufler S; Naumann M; Reinhardt P; Sterneckert J; Kefalakes E; Kassebaum C; Bursch F; Lojewski X; Storch A; Frickenhaus M; Boeckers TM; Putz S; Demestre M; Liebau S; Klingenstein M; Ludolph AC; Dengler R; Kim KS; Hermann A; Wegner F; Petri S
Stem Cells; 2016 Jun; 34(6):1563-75. PubMed ID: 26946488
[TBL] [Abstract][Full Text] [Related]
15. Differentiation but not ALS mutations in FUS rewires motor neuron metabolism.
Vandoorne T; Veys K; Guo W; Sicart A; Vints K; Swijsen A; Moisse M; Eelen G; Gounko NV; Fumagalli L; Fazal R; Germeys C; Quaegebeur A; Fendt SM; Carmeliet P; Verfaillie C; Van Damme P; Ghesquière B; De Bock K; Van Den Bosch L
Nat Commun; 2019 Sep; 10(1):4147. PubMed ID: 31515480
[TBL] [Abstract][Full Text] [Related]
16. Induced pluripotent stem cell-derived motor neurons from amyotrophic lateral sclerosis (ALS) patients carrying different superoxide dismutase 1 mutations recapitulate pathological features of ALS.
Liu WC; Liu N; Wang Y; Huang C; Li YF; Wang H; Li XG; Deng M
Chin Med J (Engl); 2021 Oct; 134(20):2457-2464. PubMed ID: 34669638
[TBL] [Abstract][Full Text] [Related]
17. Genetic Correction of SOD1 Mutant iPSCs Reveals ERK and JNK Activated AP1 as a Driver of Neurodegeneration in Amyotrophic Lateral Sclerosis.
Bhinge A; Namboori SC; Zhang X; VanDongen AMJ; Stanton LW
Stem Cell Reports; 2017 Apr; 8(4):856-869. PubMed ID: 28366453
[TBL] [Abstract][Full Text] [Related]
18. Differentiation of control and ALS mutant human iPSCs into functional skeletal muscle cells, a tool for the study of neuromuscolar diseases.
Lenzi J; Pagani F; De Santis R; Limatola C; Bozzoni I; Di Angelantonio S; Rosa A
Stem Cell Res; 2016 Jul; 17(1):140-7. PubMed ID: 27318155
[TBL] [Abstract][Full Text] [Related]
19. Induced pluripotent stem cells in modeling and cell-based therapy of amyotrophic lateral sclerosis.
Csobonyeiova M; Polak S; Nicodemou A; Danisovic L
J Physiol Pharmacol; 2017 Oct; 68(5):649-657. PubMed ID: 29375039
[TBL] [Abstract][Full Text] [Related]
20. Gamma motor neurons survive and exacerbate alpha motor neuron degeneration in ALS.
Lalancette-Hebert M; Sharma A; Lyashchenko AK; Shneider NA
Proc Natl Acad Sci U S A; 2016 Dec; 113(51):E8316-E8325. PubMed ID: 27930290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
